Cargando…

Thyroid Hormone in Hepatocellular Carcinoma: Cancer Risk, Growth Regulation, and Anticancer Drug Resistance

Thyroid hormone (TH) and its receptor (TR) are involved in differentiation, metabolic process, and growth regulation in hepatocellular carcinoma (HCC). The TH/TR complexes are ligand-dependent transcriptional factors, functioning through binding to thyroid hormone response elements (TREs) upstream o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Yang-Hsiang, Lin, Kwang-Huei, Yeh, Chau-Ting
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7258858/ https://www.ncbi.nlm.nih.gov/pubmed/32528965 http://dx.doi.org/10.3389/fmed.2020.00174

Ejemplares similares

Roles of Thyroid Hormone-Associated microRNAs Affecting Oxidative Stress in Human Hepatocellular Carcinoma
por: Huang, Po-Shuan, et al.
Publicado: (2019)

Thyroid hormone suppresses expression of stathmin and associated tumor growth in hepatocellular carcinoma
por: Tseng, Yi-Hsin, et al.
Publicado: (2016)

Molecular Functions of Thyroid Hormone Signaling in Regulation of Cancer Progression and Anti-Apoptosis
por: Liu, Yu-Chin, et al.
Publicado: (2019)

Thyroid hormone inhibits growth of hepatoma cells through induction of miR-214
por: Huang, Po-Shuan, et al.
Publicado: (2017)

Molecular functions and clinical impact of thyroid hormone-triggered autophagy in liver-related diseases
por: Chi, Hsiang-Cheng, et al.
Publicado: (2019)

Induction of nuclear protein-1 by thyroid hormone enhances platelet-derived growth factor A mediated angiogenesis in liver cancer
por: Chen, Ching-Ying, et al.
Publicado: (2019)

ChIP-on-chip analysis of thyroid hormone-regulated genes and their physiological significance
por: Chung, I-Hsiao, et al.
Publicado: (2016)

Reply to Comments: “Molecular Functions of Thyroid Hormone Signaling in Regulation of Cancer Progression and Anti-Apoptosis” Int. J. Mol. Sci., 2019, 20, 4986
por: Liu, Yu-Chin, et al.
Publicado: (2020)

TUG1 Is a Regulator of AFP and Serves as Prognostic Marker in Non-Hepatitis B Non-Hepatitis C Hepatocellular Carcinoma †
por: Lin, Yang-Hsiang, et al.
Publicado: (2020)

Stimulation of Interferon-Stimulated Gene 20 by Thyroid Hormone Enhances Angiogenesis in Liver Cancer
por: Lin, Syuan-Ling, et al.
Publicado: (2017)

Cancer Stem Cell Functions in Hepatocellular Carcinoma and Comprehensive Therapeutic Strategies
por: Liu, Yu-Chin, et al.
Publicado: (2020)

Correction: Lin, K.-H., et al. Molecular Functions of Thyroid Hormone Signaling in Regulation of Cancer Progression and Anti-Apoptosis. Int. J. Mol. Sci., 2019, 20, 4986
por: Liu, Yu-Chin, et al.
Publicado: (2020)

LPAL2 Suppresses Tumor Growth and Metastasis of Hepatocellular Carcinoma by Modulating MMP9 Expression
por: Lin, Yang-Hsiang, et al.
Publicado: (2022)

Effects of Thyroid Hormones on Lipid Metabolism Pathologies in Non-Alcoholic Fatty Liver Disease
por: Liao, Chia-Jung, et al.
Publicado: (2022)

Radiosensitization of Hepatocellular Carcinoma through Targeting Radio-Associated MicroRNA
por: Wu, Cheng-Heng, et al.
Publicado: (2020)

Furin Overexpression Suppresses Tumor Growth and Predicts a Better Postoperative Disease-Free Survival in Hepatocellular Carcinoma
por: Huang, Ya-Hui, et al.
Publicado: (2012)

Dysregulated FAM215A Stimulates LAMP2 Expression to Confer Drug-Resistant and Malignant in Human Liver Cancer
por: Huang, Po-Shuan, et al.
Publicado: (2020)

Biological Functions of Thyroid Hormone in Placenta
por: Chen, Cheng-Yi, et al.
Publicado: (2015)

Thyroid hormone enhanced human hepatoma cell motility involves brain-specific serine protease 4 activation via ERK signaling
por: Chen, Cheng-Yi, et al.
Publicado: (2014)

Molecular Functions of Thyroid Hormones and Their Clinical Significance in Liver-Related Diseases
por: Chi, Hsiang Cheng, et al.
Publicado: (2013)

Roles of Long Noncoding RNAs in Recurrence and Metastasis of Radiotherapy-Resistant Cancer Stem Cells
por: Chi, Hsiang-Cheng, et al.
Publicado: (2017)

Chemotherapy resistance and metastasis-promoting effects of thyroid hormone in hepatocarcinoma cells are mediated by suppression of FoxO1 and Bim pathway
por: Chi, Hsiang-Cheng, et al.
Publicado: (2016)

Long Non-Coding RNAs as Mediators of Tumor Microenvironment and Liver Cancer Cell Communication
por: Lin, Yang-Hsiang, et al.
Publicado: (2018)

The impact of thyroid hormones on patients with hepatocellular carcinoma
por: Pinter, Matthias, et al.
Publicado: (2017)

Cyclin-dependent kinase-associated protein phosphatase is overexpressed in alcohol-related hepatocellular carcinoma and influences xenograft tumor growth
por: LIN, WEY-RAN, et al.
Publicado: (2012)

COX5B-Mediated Bioenergetic Alterations Modulate Cell Growth and Anticancer Drug Susceptibility by Orchestrating Claudin-2 Expression in Colorectal Cancers
por: Chu, Yu-De, et al.
Publicado: (2021)

Functional roles of non-coding RNAs regulated by thyroid hormones in liver cancer
por: Huang, Po-Shuan, et al.
Publicado: (2021)

Thyroid hormone-mediated regulation of lipocalin 2 through the Met/FAK pathway in liver cancer
por: Chung, I-Hsiao, et al.
Publicado: (2015)

The Molecular Function and Clinical Role of Thyroid Stimulating Hormone Receptor in Cancer Cells
por: Chu, Yu-De, et al.
Publicado: (2020)

Clinical Limitations of Tissue Annexin A2 Level as a Predictor of Postoperative Overall Survival in Patients with Hepatocellular Carcinoma
por: Huang, Shu-Wei, et al.
Publicado: (2021)

Mifepristone inhibits hepatoma growth by enhancing the GR-HSP60-survivin interaction to facilitate survivin degradation
por: Huang, Ya-Hui, et al.
Publicado: (2023)

Bone Densities Assessed by Hounsfield Units at L5 in Computed Tomography Image Independently Predict Hepatocellular Carcinoma Development in Cirrhotic Patients
por: Yeh, Christopher, et al.
Publicado: (2022)

Evaluation and Application of Drug Resistance by Biomarkers in the Clinical Treatment of Liver Cancer
por: Huang, Po-Shuan, et al.
Publicado: (2023)

SUN-025 Thyroid Hormone Suppresses FOXM1 Expression to Reduce Liver Cancer Progression
por: Lin, Kwang-Huei, et al.
Publicado: (2019)

Impact of an MT-RNR1 Gene Polymorphism on Hepatocellular Carcinoma Progression and Clinical Characteristics
por: Lin, Yang-Hsiang, et al.
Publicado: (2021)

Is there a sex difference in postoperative prognosis of hepatocellular carcinoma?
por: Lai, Ming-Wei, et al.
Publicado: (2019)

Identification of Postoperative Prognostic MicroRNA Predictors in Hepatocellular Carcinoma
por: Huang, Ya-Hui, et al.
Publicado: (2012)

Coexistence of resistance to thyroid hormone and papillary thyroid carcinoma
por: Igata, Motoyuki, et al.
Publicado: (2016)

Editorial: Advances in chemotherapy-resistant hepatocellular carcinoma
por: Liu, Shui, et al.
Publicado: (2023)

Assessing Specificity of Anticancer Drugs In Vitro
por: Kluwe, Lan
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_7d2j2fg5u593f57f199u1vf2up